Holmes, 37, was facing an indictment of 11 total charges: Nine counts of wire fraud and two counts of conspiracy related to alleged falsehoods regarding tests produced by Theranos. This includes indictments against patients of the company as well as institutional investors.

Of these charges, Holmes was convicted of one count of conspiracy and three counts of fraud. She was found not guilty of four other charges.

Holmes now faces up to 20 years in prison and a fine of $250,000. However, legal experts stated that her sentence will likely be shorter given her acquittal on four charges.

The remaining trio of fraud charges went without a verdict after the jury stated they were unable to come to a unanimous decision, although prosecutors can choose to initiate a new trial on these counts.

KTVU-TV reporter Evan Sernoffsky, who was covering the San Jose, California-based trial live from the courtroom, stated on Twitter that Holmes “has not flinched” even after the guilty verdicts were read out. Her family, who came to the trial with Holmes, was also reportedly emotionless.

In total, the jury reached their decisions after a three-month trial that captivated the nation.

The group of eight men and four women spent about 45 total hours over the course of six days following closing arguments discussing the facts of the case. This included perusing hundreds of documents and direct testimony from both the prosecution and the defense.

The convictions against Holmes represented a significant fall from grace for the woman whom Forbes called the United States’ wealthiest and youngest self-made female billionaire in 2015.

Founding her Silicon Valley startup, Theranos, in 2003 at the age of 19, Holmes built a massive corporation that claimed to have created groundbreaking blood-testing technology that “revolutionized” the healthcare industry. It was claimed that these tests could identify over 1,000 datasets from a single drop of blood.

Holmes raised over $900 million that was made up of a number of massive investments, including a single round of capital, wired to Theranos in 2014, valued at nearly $100 million. Many of these investments were from high-profile business moguls such as Oracle founder Larry Ellison and media titan Rupert Murdoch.

This helped to grow Theranos to a valuation of $9 billion in 2015.

However, at the height of the company’s success, The Wall Street Journal published multiple investigative reports that showed Theranos’ blood tests were not nearly as all-inclusive as they claimed to be, and came back with numerous errors.

Holmes was initially indicted in 2018, but the trial was significantly delayed by the COVID-19 pandemic, as well as Holmes’ pregnancy.

Once the trial finally got underway this past August, prosecutors alleged that Holmes was aware of the limitations of the company’s tests, but had deliberately defrauded investors by exaggerating their capabilities.

Holmes had furiously defended her company even after intense media scrutiny following the Journal’s reports. She echoed this sentiment in court during testimony, and the defense counsel argued that her broad claims of the blood tests’ capabilities did not amount to illegal activity.

Ramesh Balwani, the former president and COO of Theranos, as well as Holmes’ former boyfriend, is also facing charges of fraud and conspiracy related to his running of the company’s financials.

Update (01/03/2022, 8 p.m. ET): This story has been updated with additional information.